{"id":"W4417148749","doi":"10.1016/j.annonc.2025.11.020","title":"Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Bevacizumab; Durvalumab; Olaparib; Ovarian cancer; Prostate cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004159342,0.0001936237,0.0009181249,0.0001685614,0.0001757077,0.000414875,0.0003151243,0.0003242191,0.00134094],"category_scores_gemma":[0.0009013892,0.0001239758,0.0005176742,0.0002335332,0.0001734343,0.0003523105,0.0001665362,0.0009300391,0.0001257088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008095348,"about_ca_system_score_gemma":0.00074878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001825171,"about_ca_topic_score_gemma":0.008939108,"domain_scores_codex":[0.9998453,0.00004436489,0.00001792918,0.00003360807,0.00001864549,0.00004031199],"domain_scores_gemma":[0.9997306,0.00008834513,0.00004476669,0.00001808853,0.000009856611,0.0001082574],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4183441,0.006151177,0.04621331,0.001285712,0.002486931,0.002376155,0.0002860676,0.00393282,0.01971961,0.0009166236,0.004922307,0.4933653],"study_design_scores_gemma":[0.2082489,0.2082401,0.4799706,0.000547945,0.005762847,0.01396496,0.0006859464,0.01683645,0.02236391,0.001981955,0.04123744,0.0001588755],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907765,0.006328297,0.0001710971,0.0003969403,0.0001779218,0.00009043171,0.000165291,0.00002407901,0.00186954],"genre_scores_gemma":[0.9969712,0.001757562,0.000346973,0.0001754867,0.0000509183,0.00003222462,0.0001548729,0.00000410451,0.0005065741],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001825171,"threshold_uncertainty_score":0.005873621,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02540844838438732,"score_gpt":0.3711802441592098,"score_spread":0.3457717957748225,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}